250 related articles for article (PubMed ID: 10882539)
1. Molecular pathogenesis of pituitary tumors.
Farrell WE; Clayton RN
Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
[TBL] [Abstract][Full Text] [Related]
2. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
[TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the p16/CDKN2A/MTSI gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas.
Simpson DJ; Bicknell JE; McNicol AM; Clayton RN; Farrell WE
Genes Chromosomes Cancer; 1999 Apr; 24(4):328-36. PubMed ID: 10092131
[TBL] [Abstract][Full Text] [Related]
6. Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.
Simpson DJ; Hibberts NA; McNicol AM; Clayton RN; Farrell WE
Cancer Res; 2000 Mar; 60(5):1211-6. PubMed ID: 10728677
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
8. Methylation mechanisms in pituitary tumorigenesis.
Farrell WE; Simpson DJ; Frost SJ; Clayton RN
Endocr Relat Cancer; 1999 Dec; 6(4):437-47. PubMed ID: 10730899
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation.
Bahar A; Bicknell JE; Simpson DJ; Clayton RN; Farrell WE
Oncogene; 2004 Jan; 23(4):936-44. PubMed ID: 14647444
[TBL] [Abstract][Full Text] [Related]
11. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
Pollock PM; Welch J; Hayward NK
Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
[TBL] [Abstract][Full Text] [Related]
12. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic mechanisms of tumorigenesis.
Farrell WE
Horm Metab Res; 2005 Jun; 37(6):361-8. PubMed ID: 16001328
[TBL] [Abstract][Full Text] [Related]
14. Tumour suppressor genes in pituitary tumour formation.
Farrell WE; Clayton RN
Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Oct; 13(3):381-93. PubMed ID: 10909430
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
16. Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors.
Orlow I; Lianes P; Lacombe L; Dalbagni G; Reuter VE; Cordon-Cardo C
Cancer Res; 1994 Jun; 54(11):2848-51. PubMed ID: 8187066
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors.
Hibberts NA; Simpson DJ; Bicknell JE; Broome JC; Hoban PR; Clayton RN; Farrell WE
Clin Cancer Res; 1999 Aug; 5(8):2133-9. PubMed ID: 10473097
[TBL] [Abstract][Full Text] [Related]
18. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]